Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
Clinical trial NCT00781274 · COMPLETED
Trial details
- NCT number
- NCT00781274
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.